Found: 9
Select item for more details and to access through your institution.
Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosis strain.
- Published in:
- BMC Pulmonary Medicine, 2009, v. 9, p. 1, doi. 10.1186/1471-2466-9-3
- By:
- Publication type:
- Article
Adecuación de la prescripción de antibióticos antipseudomónicos tras los cambios en los criterios EUCAST 2019.
- Published in:
- Revista Española de Quimioterapia, 2023, v. 36, n. 5, p. 470, doi. 10.37201/req/137.2022
- By:
- Publication type:
- Article
Estudio de utilización en práctica clínica real de ceftolozano/tazobactam frente a aminoglucósidos y/o colistina en el tratamiento de Pseudomonas aeruginosa.
- Published in:
- Revista Española de Quimioterapia, 2021, v. 34, n. 5, p. 441, doi. 10.37201/req/006.2021
- By:
- Publication type:
- Article
Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drugresistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital.
- Published in:
- Revista Española de Quimioterapia, 2019, v. 32, n. 1, p. 68
- By:
- Publication type:
- Article
Beyond CC398: Characterisation of Other Tetracycline and Methicillin-Resistant Staphylococcus aureus Genetic Lineages Circulating in Spanish Hospitals.
- Published in:
- Pathogens, 2022, v. 11, n. 3, p. 307, doi. 10.3390/pathogens11030307
- By:
- Publication type:
- Article
Actinobaculum schaalii recurrent urinary infection in a centenarian patient.
- Published in:
- Geriatrics & Gerontology International, 2013, v. 13, n. 3, p. 807, doi. 10.1111/ggi.12039
- By:
- Publication type:
- Article
Prevalence and Genetic Characteristics of Staphylococcus aureus CC398 Isolates From Invasive Infections in Spanish Hospitals, Focusing on the Livestock-Independent CC398-MSSA Clade.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2021.623108
- By:
- Publication type:
- Article
In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39647-9
- By:
- Publication type:
- Article
In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39647-9
- By:
- Publication type:
- Article